100 related articles for article (PubMed ID: 21299955)
1. [Prediction of the metastatic potential of sarcomas on the basis of a gene expression signature related to genome complexity].
Chibon F
Med Sci (Paris); 2011 Jan; 27(1):22-4. PubMed ID: 21299955
[No Abstract] [Full Text] [Related]
2. [Gene expression analysis using DNA microarrays in soft tissue and bone tumors].
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels R
Dtsch Med Wochenschr; 2003 Sep; 128(39):2030-6. PubMed ID: 14508699
[No Abstract] [Full Text] [Related]
3. A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
Lee YF; John M; Falconer A; Edwards S; Clark J; Flohr P; Roe T; Wang R; Shipley J; Grimer RJ; Mangham DC; Thomas JM; Fisher C; Judson I; Cooper CS
Cancer Res; 2004 Oct; 64(20):7201-4. PubMed ID: 15492233
[TBL] [Abstract][Full Text] [Related]
4. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB
Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
[TBL] [Abstract][Full Text] [Related]
7. cDNA microarray-based translational research in soft tissue sarcoma.
Lubieniecka JM; Nielsen TO
J Surg Oncol; 2005 Dec; 92(4):267-71. PubMed ID: 16299802
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
9. Genetics of soft tissue tumors.
van de Rijn M; Fletcher JA
Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
[TBL] [Abstract][Full Text] [Related]
10. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type.
Nakayama R; Mitani S; Nakagawa T; Hasegawa T; Kawai A; Morioka H; Yabe H; Toyama Y; Ogose A; Toguchida J; Nakayama T; Yoshida T; Ichikawa H
Am J Surg Pathol; 2010 Nov; 34(11):1599-607. PubMed ID: 20975339
[TBL] [Abstract][Full Text] [Related]
12. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
13. [Targeted therapies in soft-tissue and visceral sarcomas].
Emile JF
Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
[No Abstract] [Full Text] [Related]
14. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research].
Ferté C; Pascal LB; Penel N
Bull Cancer; 2009 Apr; 96(4):451-60. PubMed ID: 19357019
[TBL] [Abstract][Full Text] [Related]
16. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.
Masciullo V; Berardengo E; Boglione A; Sgambato A; Bernardi A; Forni M; Linari A; Cito L; Scambia G; Comandone A; Giordano A
Clin Cancer Res; 2008 Aug; 14(15):4775-9. PubMed ID: 18676747
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetic data on sarcomas of the bone and soft tissue].
Aurias A
Bull Cancer; 1988; 75(5):423-9. PubMed ID: 3165034
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
Rydholm A; Gustafson P; Alvegård TA; Saeter G; Blomqvist C
Acta Orthop Scand Suppl; 1999 Jun; 285():50-7. PubMed ID: 10429623
[No Abstract] [Full Text] [Related]
19. A three-gene signature for outcome in soft tissue sarcoma.
Hoffmann AC; Danenberg KD; Taubert H; Danenberg PV; Wuerl P
Clin Cancer Res; 2009 Aug; 15(16):5191-8. PubMed ID: 19671876
[TBL] [Abstract][Full Text] [Related]
20. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
